Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR2 | O60603 | 12/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25869419 | 0.86 | TLR2 (0.42) | TLR2 | |
| SCHEMBL25869429 | 0.85 | PTPN1 (0.42) | TLR2PTPN1 | |
| SCHEMBL25869422 | 0.85 | PTPN1 (0.42) | TLR2PTPN1 | |
| SCHEMBL26309045 | 0.85 | TLR2 (0.49) | TLR2TBXAS1 | |
| SCHEMBL30396412 | 0.84 | TLR2 (0.49) | TLR2TBXAS1 | |
| SCHEMBL26305176 | 0.83 | TLR2 (0.47) | TLR2TBXAS1 | |
| SCHEMBL25873598 | 0.83 | TLR2 (0.36) | TLR2 | |
| SCHEMBL25874600 | 0.81 | TLR2 (0.41) | TLR2 | |
| SCHEMBL31647809 | 0.81 | CYP3A4 (0.47) | TLR2PTPN1 | |
| SCHEMBL16826374 | 0.81 | CYP3A4 (0.49) | TLR2PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230233468-A1 | LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2023-07-27 | — | — | US | disclosed |
| US-20230233468-A1 | LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230233468-A1 | LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | CETP, NPC1, LCAT | TLR2 1063/4885PTPN1 2202/4885TBXAS1 1992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.